Suggestions
Shelly Cummings
Medical Science Liaison at Myriad Genetic Laboratories Inc.
Shelly Cummings is a highly experienced Medical Science Liaison, III specializing in Hereditary Cancer at Myriad Genetic Laboratories. With a diverse background spanning 23 years as a cancer Genetic Counselor, educator, and published author, Shelly brings a wealth of knowledge and expertise to her current role.
Shelly is renowned for her exceptional skills as an relationship builder, communicator, and presenter. She has a proven track record of developing strong professional relationships and possesses a keen understanding of various perspectives within the industry.
A strategic analytical thinker, Shelly excels at problem-solving and devising innovative solutions. Her detail-oriented and results-driven approach has established her as a leader with exceptional people management capabilities, allowing her to influence positively across organizational hierarchies.
Having a deep passion for mentoring and inspiring others, Shelly is dedicated to helping individuals reach their personal and professional goals. She leverages her unique strengths on a daily basis to make a positive impact on the lives of individuals affected by cancer or at risk of developing the disease.
Shelly's educational background includes a Master Of Arts In Counseling from Northwestern University - The Feinberg School Of Medicine and a Bachelor Of Science In Biology and Psychology from Indiana University Bloomington.
Shelly has held various key positions throughout her career, including Director of Oncology Medical Affairs, Medical Science Liaison, Institutional Accounts Manager, and Genetic Counselor at Myriad Genetics. Prior to her roles at Myriad, she served as the Manager for Northeast Oncology, Regional Medical Specialists and as a Regional Medical Specialist and Genetic Counselor at Myriad Genetic Laboratories Inc. She also contributed as an Assistant Program Director at the University Of Chicago Medicine.
Shelly Cummings' expertise, leadership qualities, and dedication to the field of cancer genetics make her an invaluable asset to the healthcare industry.
